Arylamine N-Acetyltransferase
"Arylamine N-Acetyltransferase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the transfer of acetyl groups from ACETYL-COA to arylamines. It can also catalyze acetyl transfer between arylamines without COENZYME A and has a wide specificity for aromatic amines, including SEROTONIN. However, arylamine N-acetyltransferase should not be confused with the enzyme ARYLALKYLAMINE N-ACETYLTRANSFERASE which is also referred to as SEROTONIN ACETYLTRANSFERASE.
Descriptor ID |
D001191
|
MeSH Number(s) |
D08.811.913.050.134.138
|
Concept/Terms |
Arylamine N-Acetyltransferase- Arylamine N-Acetyltransferase
- Arylamine N Acetyltransferase
- N-Acetyltransferase, Arylamine
- Arylamine Acetyltransferases
- Acetyltransferases, Arylamine
- Arylamine Acetylases
- Acetylases, Arylamine
- Acetyl-CoA Arylamine N-Acetyltransferase
- Acetyl CoA Arylamine N Acetyltransferase
- Arylamine N-Acetyltransferase, Acetyl-CoA
- N-Acetyltransferase, Acetyl-CoA Arylamine
- Arylamine Acetylase
- Acetylase, Arylamine
|
Below are MeSH descriptors whose meaning is more general than "Arylamine N-Acetyltransferase".
Below are MeSH descriptors whose meaning is more specific than "Arylamine N-Acetyltransferase".
This graph shows the total number of publications written about "Arylamine N-Acetyltransferase" by people in this website by year, and whether "Arylamine N-Acetyltransferase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2012 | 1 | 1 | 2 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arylamine N-Acetyltransferase" by people in Profiles.
-
Influence of N-acetyltransferase 2 gene polymorphisms on the in vitro metabolism of the epidermal growth factor receptor inhibitor rociletinib. Br J Clin Pharmacol. 2021 11; 87(11):4313-4322.
-
N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians. Pharmacogenet Genomics. 2019 07; 29(5):106-113.
-
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium. Cancer Causes Control. 2013 Jan; 24(1):125-34.
-
Meat intake and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2012 Oct; 23(10):1681-92.
-
Genetic polymorphisms in cytochrome P450s, GSTs, NATs, alcohol consumption and risk of non-Hodgkin lymphoma. Am J Hematol. 2010 Mar; 85(3):213-5.
-
Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2010 Jan; 21(1):127-33.
-
Multiple advantageous amino acid variants in the NAT2 gene in human populations. PLoS One. 2008 Sep 05; 3(9):e3136.
-
Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet. 2006 Mar; 78(3):423-36.
-
Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke. Carcinogenesis. 2003 Apr; 24(4):719-25.
-
Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease. Mov Disord. 2000 Jul; 15(4):714-9.